BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 4744572)

  • 1. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
    Gaines JD; Gilmer MA; Remington JS
    Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Eltringham JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
    Babacan E; Cavdar AO; Arcasoy A
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease].
    Ferrari S; Foggi CM; Serafini NA
    Ann Ist Carlo Forlanini; 1968; 28(3):292-309. PubMed ID: 4903142
    [No Abstract]   [Full Text] [Related]  

  • 10. [The immune response in Hodgkin's disease].
    Schneider M; Schwarzenberg L; Amiel JL; Hayat M; Mascaro G; Otmezguine Y; Mathé G
    Presse Med (1893); 1970 Oct; 78(41):1769-74. PubMed ID: 4097017
    [No Abstract]   [Full Text] [Related]  

  • 11. [T-lymphocytes and their function in Hodgkin's disease (author's transl)].
    Michlmayr G
    Wien Klin Wochenschr Suppl; 1977; 71():3-15. PubMed ID: 301687
    [No Abstract]   [Full Text] [Related]  

  • 12. Degrees of impairment of cell-mediated immune reactivity in Hodgkin's disease.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):201-10. PubMed ID: 61913
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hypersensitivity in untreated patients with Hodgkin's disease--with special reference to small lymphocyte counts in the blood.
    Tanaka M
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):61-72. PubMed ID: 989232
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune deficiency in malignant lymphomas.
    Konopka L; Pawelski S; Maślanka K; Zupańska B; Cieśluk S
    Chemioterapia; 1987 Jun; 6(2 Suppl):745-8. PubMed ID: 3509538
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating lymphoid cells in Hodgkin's disease.
    Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():95-8. PubMed ID: 4270378
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrinsic lymphocyte defect in Hodgkin's disease: analysis of the phytohemagglutinin dose-response.
    Ziegler JB; Hansen P; Penny R
    Clin Immunol Immunopathol; 1975 Mar; 3(4):451-60. PubMed ID: 803886
    [No Abstract]   [Full Text] [Related]  

  • 19. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 20. [Delayed hypersensitivity in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):377-81. PubMed ID: 4563128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.